Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.4M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
1.79M
-
Shares change
-
+250K
-
Total reported value, excl. options
-
$111M
-
Value change
-
+$16M
-
Number of buys
-
2
-
Number of sells
-
-1
-
Price
-
$61.85
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q4 2023
3 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q4 2023.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.79M shares
of 46.4M outstanding shares and own 3.87% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.04M shares), FEDERATED HERMES, INC. (3.27M shares), VANGUARD GROUP INC (2.82M shares), NEUBERGER BERMAN GROUP LLC (1.69M shares), STATE STREET CORP (1.47M shares), DIMENSIONAL FUND ADVISORS LP (1.34M shares), FULLER & THALER ASSET MANAGEMENT, INC. (1.27M shares), GEODE CAPITAL MANAGEMENT, LLC (847K shares), TD ASSET MANAGEMENT INC (794K shares), and RENAISSANCE TECHNOLOGIES LLC (642K shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.